http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020506902-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2020506902-A |
| titleOfInvention | Substituted pyrazolo [1,5-a] pyrazine compounds as RET kinase inhibitors |
| abstract | Compounds of Formula I, and stereoisomers and pharmaceutically acceptable salts or solvates thereof, are provided herein, wherein A, B, D, E, X 1 , X 2 , X 3 , and X 4, RET inhibitors of kinases, have the meaning given herein, including diseases and disorders mediated by RET kinase, diseases that can be treated with RET kinase inhibitor Useful for treatment and prevention. Embedded image |
| priorityDate | 2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1337.